Pluristem (PSTI) - Total Liabilities

Latest as of March 2022: ILA38.98 Million ILA ≈ $104.51K USD

Based on the latest financial reports, Pluristem (PSTI) has total liabilities worth ILA38.98 Million ILA (≈ $104.51K USD) as of March 2022. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of Pluristem's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Pluristem - Total Liabilities Trend (2014–2021)

This chart illustrates how Pluristem's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Pluristem.

Pluristem Competitors by Total Liabilities

The table below lists competitors of Pluristem ranked by their total liabilities.

Company	Country	Total Liabilities
Etiler İnci Bufe Gida Sanayi ve Dis Ticaret AS IS:ETILR	Turkey	TL802.86 Million
Tera Software Limited NSE:TERASOFT	India	Rs1.56 Billion
Shanghai Material Trading Co Ltd B SHG:900927	China	$463.81 Million
FiEE, Inc. NASDAQ:FIEE	USA	$3.86 Million
Slj Global Tbk JK:SULI	Indonesia	Rp486.05 Billion
NovaBay Pharmaceuticals Inc NYSE MKT:NBY	USA	$31.86 Million
Dental Corporation Public Company Limited BK:D	Thailand	฿543.92 Million
Brixton Metals Corporation V:BBB	Canada	CA$3.21 Million

Liability Composition Analysis (2014–2021)

This chart breaks down Pluristem's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Pluristem (PSTI) net asset quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	8.22	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.02	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.49	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Pluristem's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Pluristem (2014–2021)

The table below shows the annual total liabilities of Pluristem from 2014 to 2021.

Year	Total Liabilities	Change
2021-06-30	ILA36.39 Million ≈ $97.55K	+285.82%
2020-06-30	ILA9.43 Million ≈ $25.28K	-0.61%
2019-06-30	ILA9.49 Million ≈ $25.44K	-9.22%
2018-06-30	ILA10.45 Million ≈ $28.02K	+43.53%
2017-06-30	ILA7.28 Million ≈ $19.53K	-6.45%
2016-06-30	ILA7.79 Million ≈ $20.87K	-22.24%
2015-06-30	ILA10.01 Million ≈ $26.84K	-15.87%
2014-06-30	ILA11.90 Million ≈ $31.90K	--

About Pluristem

TA:PSTI Israel Biotechnology & Medical Research

Market Cap

$32.23 Million

ILA12.02 Billion ILA

Market Cap Rank

#23603 Global

#329 in Israel

Share Price

ILA371.60

Change (1 day)

+0.16%

52-Week Range

ILA371.00 - ILA1598.00

All Time High

ILA72010.00